Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemox”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Not applicableUnknownNCT04432402
What this trial is testing

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 124
Testing effectiveness (Phase 2)Looking for participantsNCT05668884
What this trial is testing

GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Fudan University 93
Testing effectiveness (Phase 2)Study completedNCT01389414
What this trial is testing

Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Carcinoma
Prof. Massimo Aglietta 89
Testing effectiveness (Phase 2)Looking for participantsNCT06925516
What this trial is testing

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07184788
What this trial is testing

G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma

Who this might be right for
Aggressive B-Cell Lymphoma
Navy General Hospital, Beijing 80
Testing effectiveness (Phase 2)Study completedNCT01562990
What this trial is testing

Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse

Who this might be right for
Diffuse Large B-Cell Lymphoma
The Lymphoma Academic Research Organisation 11
Testing effectiveness (Phase 2)Study completedNCT01487720
What this trial is testing

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Asan Medical Center 33
Large-scale testing (Phase 3)UnknownNCT02548195
What this trial is testing

Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Shanghai Zhongshan Hospital 286
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Large-scale testing (Phase 3)UnknownNCT01470443
What this trial is testing

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer
Samsung Medical Center 240
Not applicableLooking for participantsNCT05215665
What this trial is testing

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 146
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05919095
What this trial is testing

A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer

Who this might be right for
Unresectable Gallbladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07122609
What this trial is testing

Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed and Refractory DLBCL
Ruijin Hospital 22
Testing effectiveness (Phase 2)Looking for participantsNCT05430698
What this trial is testing

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Who this might be right for
Perihilar Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365306
What this trial is testing

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Primary Mediastinal Large B-Cell Lymphoma+5 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT05517239
What this trial is testing

Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

Who this might be right for
Hepatocellular Carcinoma, Unresectable, Advanced
Yonsei University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06583083
What this trial is testing

Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Sun Yat-sen University 84
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06313203
What this trial is testing

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

Who this might be right for
Intrahepatic CholangiocarcinomaChemotherapy Effect
Oslo University Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06601504
What this trial is testing

Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hutchmed 61
Load More Results
43